Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från ProstaLund AB (publ) via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
2023-07-14 08:15:00
– Fifth consecutive quarter of growth
1 April-30 June
- Net sales reached SEK 5,4 (3,5) million
- Loss after taxes SEK -4,1 (-3,7) million
- Earnings per share were SEK -0,07 (-0,07)
- Cash and equivalents were 34,4 (4,4) million
Significant events during period
- Distribution agreement signed in Poland
- Distribution agreement signed in Switzerland
- The Board decides on a rights issue
- The rights issue was subscribed to 85% and brought the company approximately SEK 34 million in capital before issue costs
1 January-30 June
- Net sales reached SEK 10,9 (8,1) million
- Loss after taxes SEK -7,3 (-5,8) million
- Earnings per share were SEK -0,10 (-0,11)
Significant events after the period
- The company decided to withdraw the 510(k) application in the USA, for the Schelin Catheter®
- The company decided that it intends to apply De Novo for Schelin Catheter®
Nyckeltal | |||
(SEK MILLION) ) | Jan-June 2023 | Jan-June 2022 | Jan-June 2021 |
Net sales | 11 | 8,1 | 8,5 |
Gross margin, % | 68 | 76 | 87 |
Operating profit/loss | -7,2 | -5,8 | -3,9 |
Cash flow from operating activities | -6,1 | -9,5 | -3,2 |
Average number of employees | 9 | 7 | 7 |
”The great interest in all our products, not only the stand-alone products but also CoreTherm, in several countries makes us look with confidence to the future”.
Johan Wennerholm
CEO, ProstaLund AB (publ)